CI
CignaPrevious close
298.23
Change
−0.18 / −0.06%
P/E (TTM) ?
12.4
Market Cap
$79.1B
1M
+9.71%
S&P 500 −0.91% over same period
Volume / Avg Volume
1.9M / 1.4M
1.31× average
Latest earnings analysisFY2026 Q2Reported 2026-07-30
Cigna Q2 2026: revenue up 7% to $71.7B, full-year outlook nudged to $30.45
Cigna's second quarter reads close to neutral: revenue rose 7.0% to $71.67 billion and adjusted earnings per share of $7.78 landed just under the $7.826 consensus, while management lifted full-year guidance by only $0.10 to at least $30.45 per share. The soft spot is margin mix, where pharmacy benefit profit fell 27.0% and Cigna Healthcare carried the quarter.
Read the full analysis →Revenue$71.67BYoY +6.70%
EPS (non-GAAP)$7.78Missest. $7.83
Next-day move−2.99%
Recent Earnings
Click to read the FinDog analysis| Period | Reported | Revenue | Analysis |
|---|---|---|---|
| FY2026 Q2 Quarter ended 2026-06 | 2026-07-30 | $71.7B | Read analysis → |
| FY2026 Q1 Quarter ended 2026-03 | 2026-04-30 | $68.5B | Pending |
| FY2025 Q4 Quarter ended 2025-12 | 2026-02-05 | $275B | Pending |
| FY2025 Q3 Quarter ended 2025-09 | 2025-10-30 | $69.7B | Pending |
| FY2025 Q2 Quarter ended 2025-06 | 2025-07-31 | $67.2B | Pending |
| FY2025 Q1 Quarter ended 2025-03 | 2025-05-02 | $65.5B | Pending |
Decision Panel
Trends · Valuation · Earnings reaction · Guidance credibility — all from company filings and market dataValuation
P/E is at percentile 22 of its 5-year rangeCheap
5-year range 11.7 – 28.1 · Median 16.8
Last 4 quarters: $1.3B in buybacks + $1.6B in dividends, 3.67% of market cap combined
P/E (TTM)
12.4
P/B
1.9
P/S
0.3
Dividend Yield
1.74%
Earnings Reaction
Over the last 6 reports, the stock moved ±2.0% on average on the first trading day after, rising 1 times
Most recent −2.99%
Volatility & Correlation
1-year beta 0.12 · Correlation with S&P 500 0.05Low beta
Annualized volatility 33% vs. 13% for the S&P 500
Insider Trading
View all →Last 90 days · Open-market buys and sells by officers and directors · Amounts in USD millions
Buy 0 · $0.00MSell 3 · $6.3MNet selling $6.3M
- 09-03Neville EverettSee RemarksSell$0.18M617 shares · Avg price 284.05
- 08-18Jones Nicole SSee RemarksSell$0.75M2,677 shares · Avg price 279.61
- 08-04Jones Nicole SSee RemarksSell$5.4M19,436 shares · Avg price 276.27
Multi-Quarter Financial Trends
View all quarters →Last 12 quarters · As reported by the company
| Quarter | Revenue ($B) | YoY | Gross Margin | Net Income ($B) | EPS |
|---|---|---|---|---|---|
| FY2026 Q2 | 71.67 | +6.7% | 20.9% | 1.66 | 6.29 |
| FY2026 Q1 | 68.49 | +4.6% | 21.0% | 1.65 | 6.26 |
| FY2025 Q4 | 72.47 | +10.4% | 20.3% | 3.10 | 4.64 |
| FY2025 Q3 | 69.75 | +9.5% | 20.4% | — | 6.98 |
| FY2025 Q2 | 67.18 | +11.0% | 20.7% | 1.53 | 5.71 |
| FY2025 Q1 | 65.50 | +14.4% | 26.1% | 1.32 | 4.85 |
| FY2024 Q4 | 65.65 | +28.4% | 25.3% | 3.43 | 5.01 |
| FY2024 Q3 | 63.69 | +29.9% | 25.3% | — | 2.63 |
| FY2024 Q2 | 60.52 | +24.6% | 26.5% | — | 5.45 |
| FY2024 Q1 | 57.26 | +23.1% | 27.6% | — | -0.97 |
| FY2023 Q4 | 51.11 | +11.7% | 31.0% | 5.16 | 3.49 |
| FY2023 Q3 | 49.05 | +8.3% | 31.4% | — | 4.74 |
| Ticker | P/E | Revenue YoY | Gross Margin | 1M | View |
|---|---|---|---|---|---|
| CI | 12.4 | +6.7% | 20.9% | +9.71% | Neutral |
| LLY | 50.2 | +38.6% | 83.9% | +22.51% | Bullish |
| JNJ | 41.3 | +5.9% | 68.1% | +3.20% | Bullish |
| ABBV | 81.4 | +10.2% | 74.7% | +12.73% | Bullish |
| UNH | 23.0 | +0.4% | 88.1% | +10.87% | Bullish |
| MRK | 117.2 | +5.1% | 73.5% | +2.90% | Neutral |
| TMO | 36.4 | +9.1% | — | +3.25% | Neutral |
| AMGN | 28.5 | +9.5% | 72.0% | +10.56% | Bullish |
| GILD | — | +6.8% | 81.1% | +14.51% | Neutral |